A CDC advisory committee is debating this issue Tuesday. Half of U.S. adults could be considered high priority yet the initial supply is likely to be only enough for 3 to 5% of the population.
(Image credit: Hans Pennink/AP)
With Limited COVID-19 Vaccine Doses, Who Would Get Them First?
